Gut-Brain Axis Newsletter
Issue #28March 16, 20267 studies

Human-derived bacteria strain reduced depression-like behavior in rats as effectively as ketamine

The gut-brain axis is having a moment. This week brought a wave of studies showing how our microbes might influence everything from depression to Parkinson's disease—and some surprising findings about what actually works.

🧬 Human gut bacteria worked as well as ketamine for depression in rats

  • Researchers gave rats a human-derived Bacteroides strain (HB32) and compared it to ketamine in a social defeat stress model—both treatments equally reduced depressive-like behavior

  • The bacterial treatment worked whether the bacteria were alive or dead (inactivated), suggesting the beneficial effects don't require living microbes

  • Stressed rats needed an intact vagus nerve to develop depression symptoms, confirming gut-brain communication was essential for the condition

Why it matters: This suggests specific bacterial strains could become precision treatments for depression, potentially offering an alternative to psychiatric drugs through the gut-brain pathway.

🥉 Top 5% journal 🔗 BMC medicine 🗓️ Mar 11

Key Findings

🧠 Clostridioides difficile predicted autism severity and brain changes in 326 children

  • A multi-omics study of 326 children with autism spectrum disorder and 169 controls found gut microbial features could accurately distinguish autism from typical development

  • Higher levels of Clostridioides difficile emerged as the strongest predictor of both autism symptom severity and brain structural variations

  • These gut-brain differences were age-dependent—they diminished as children with autism got older and converged toward typical patterns

💡 Early gut microbiome profiling could help identify autism risk and guide age-specific interventions.
🥈 Top 2% journal 🔗 Cell reports. Medicine 🗓️ Mar 10

🎯 Alpha-synuclein injected into mouse guts spread to the brain and caused Parkinson's symptoms

  • Scientists injected alpha-synuclein protein fibrils into the digestive tract of mice and tracked how the pathological protein spread throughout the nervous system

  • The gut-injected protein progressively moved to the brain and triggered both motor symptoms and sleep disturbances that mirror human Parkinson's disease

  • Dual-wavelength fiber photometry revealed disrupted dopamine and acetylcholine signaling in the brain, particularly affecting REM sleep patterns

💡 This provides direct evidence that Parkinson's pathology can start in the gut and travel to the brain via neural pathways.
🥈 Top 2% journal 🔗 Translational neurodegeneration 🗓️ Mar 11

🔬 Prebiotic fibers reduced Parkinson's depression by boosting butyrate-producing bacteria

  • Fructooligosaccharides (FOS) and galactooligosaccharides (GOS) improved both motor symptoms and depression-like behavior in a rotenone-induced Parkinson's model

  • The treatment increased butyrate-producing gut bacteria and significantly raised butyrate levels in both blood and brain tissue

  • Brain changes included increased serotonin, reduced neuroinflammation markers (α-synuclein, IL1-β), and improved synaptic proteins like BDNF and PSD-95

💡 Targeting butyrate-producing bacteria through diet could address both movement and mood symptoms in Parkinson's disease.
Top 20% journal 🔗 Inflammopharmacology 🗓️ Mar 13

📊 Female teens with depression showed distinct inflammatory and gut-brain barrier patterns

  • Among 92 adolescents with major depression, females had more severe symptoms and higher TNF-α inflammatory levels than males

  • Younger age and elevated S100β (a blood-brain barrier marker) significantly predicted non-suicidal self-injury risk in females

  • A gut-brain biomarker model achieved 84.4% accuracy in predicting self-injury risk, outperforming clinical assessments alone

💡 Blood-brain barrier dysfunction may be a key biological marker for self-harm risk in teenage girls with depression.
🥉 Top 5% journal 🔗 Journal of affective disorders 🗓️ Mar 12

🧪 Modified millet bran plus GABA-producing bacteria reduced epileptic seizures

  • Modified kodo millet bran combined with Levilactobacillus brevis (a GABA-producing bacterium) reduced seizure severity in a pentylenetetrazol epilepsy model

  • The treatment increased beneficial Turicibacter bacteria to 21.39% compared to 13.6% in untreated epileptic animals

  • Overall inflammatory cytokines dropped by 1.77-fold, while gut GABA and short-chain fatty acids increased significantly

💡 Combining specific dietary fibers with targeted bacteria could offer a gut-based approach to seizure management.
Top 20% journal 🔗 Probiotics and antimicrobial proteins 🗓️ Mar 12

🔍 Cold-hypoxia exposure raised blood pressure through gut-brain disruption in rats

  • Short-term exposure to cold (4°C) and low oxygen (61 kPa) elevated blood pressure alongside gut microbiota changes and intestinal inflammation

  • The treatment increased circulating lipopolysaccharide and inflammatory cytokines, which accumulated in brain regions controlling blood pressure

  • GABA supplementation lowered blood pressure and restored the microbiota-gut-brain axis, suppressing inflammatory signaling pathways

💡 Environmental stressors may trigger hypertension by disrupting gut-brain communication, suggesting new therapeutic targets.
Top 20% journal 🔗 Journal of hypertension 🗓️ Mar 9

Implications

This week's research reveals the gut-brain axis as a surprisingly precise biological system—specific bacterial strains can match pharmaceutical effects, protein aggregates travel predictable neural routes, and inflammatory markers can predict psychiatric risks. The findings suggest we're moving from broad "gut health" concepts toward targeted microbial interventions for neurological and psychiatric conditions.

Studies in this issue

Primary sources used for this newsletter.

  1. A human gut bacteria strain reduces depression-like behavior in rats stressed by social defeat
    main storyBMC medicine2026-03-11PMID 41808137
  2. Changes in the gut microbiome linked to physical and behavioral traits in autism
    key findingCell reports. Medicine2026-03-10PMID 41806837
  3. Parkinson’s-like symptoms start from gut protein clumps: timing of sleep and other early signs
    key findingTranslational neurodegeneration2026-03-11PMID 41808195
  4. Improving the Gut-Brain Connection with Modified Kodo Millet Bran and GABA-Producing Bacteria in a Seizure Model
    key findingProbiotics and antimicrobial proteins2026-03-12PMID 41817893
  5. Cold and low oxygen together may increase high blood pressure through the gut-brain connection
    key findingJournal of hypertension2026-03-09PMID 41800819
  6. Sex differences in inflammation and gut-brain barrier problems in teen depression linked to self-injury risk
    key findingJournal of affective disorders2026-03-12PMID 41819357
  7. Prebiotics may reduce depression, brain inflammation, and nerve cell changes in Parkinson's by boosting helpful gut bacteria that produce butyrate
    key findingInflammopharmacology2026-03-13PMID 41824184

Continue reading

All Gut-Brain Axis issues